764 related articles for article (PubMed ID: 30245977)
1. Alterations in the Abundance and Co-occurrence of
Lopez-Siles M; Enrich-Capó N; Aldeguer X; Sabat-Mir M; Duncan SH; Garcia-Gil LJ; Martinez-Medina M
Front Cell Infect Microbiol; 2018; 8():281. PubMed ID: 30245977
[No Abstract] [Full Text] [Related]
2. Changes in the Abundance of Faecalibacterium prausnitzii Phylogroups I and II in the Intestinal Mucosa of Inflammatory Bowel Disease and Patients with Colorectal Cancer.
Lopez-Siles M; Martinez-Medina M; Surís-Valls R; Aldeguer X; Sabat-Mir M; Duncan SH; Flint HJ; Garcia-Gil LJ
Inflamm Bowel Dis; 2016 Jan; 22(1):28-41. PubMed ID: 26595550
[TBL] [Abstract][Full Text] [Related]
3. Mucosa-associated Faecalibacterium prausnitzii and Escherichia coli co-abundance can distinguish Irritable Bowel Syndrome and Inflammatory Bowel Disease phenotypes.
Lopez-Siles M; Martinez-Medina M; Busquets D; Sabat-Mir M; Duncan SH; Flint HJ; Aldeguer X; Garcia-Gil LJ
Int J Med Microbiol; 2014 May; 304(3-4):464-75. PubMed ID: 24713205
[TBL] [Abstract][Full Text] [Related]
4. Mucosa-associated Faecalibacterium prausnitzii phylotype richness is reduced in patients with inflammatory bowel disease.
Lopez-Siles M; Martinez-Medina M; Abellà C; Busquets D; Sabat-Mir M; Duncan SH; Aldeguer X; Flint HJ; Garcia-Gil LJ
Appl Environ Microbiol; 2015 Nov; 81(21):7582-92. PubMed ID: 26296733
[TBL] [Abstract][Full Text] [Related]
5. The Role of Akkermansia muciniphila and Faecalibacterium prausnitzii in the Pathogenesis of Ulcerative Colitis and Crohn's Disease.
Kurt EA; Demirci M; Ozbey D; Gareayaghi N; Eskazan T; Erzin YZ; Cakan H; Saribas S; Bal K; Kocazeybek B
Clin Lab; 2024 Jan; 70(1):. PubMed ID: 38213219
[TBL] [Abstract][Full Text] [Related]
6. Similar Depletion of Protective Faecalibacterium prausnitzii in Psoriasis and Inflammatory Bowel Disease, but not in Hidradenitis Suppurativa.
Eppinga H; Sperna Weiland CJ; Thio HB; van der Woude CJ; Nijsten TE; Peppelenbosch MP; Konstantinov SR
J Crohns Colitis; 2016 Sep; 10(9):1067-75. PubMed ID: 26971052
[TBL] [Abstract][Full Text] [Related]
7. Alterations of Akkermansia muciniphila in the inflammatory bowel disease patients with washed microbiota transplantation.
Zhang T; Li P; Wu X; Lu G; Marcella C; Ji X; Ji G; Zhang F
Appl Microbiol Biotechnol; 2020 Dec; 104(23):10203-10215. PubMed ID: 33064186
[TBL] [Abstract][Full Text] [Related]
8. Systematic review and meta-analysis of the role of Faecalibacterium prausnitzii alteration in inflammatory bowel disease.
Zhao H; Xu H; Chen S; He J; Zhou Y; Nie Y
J Gastroenterol Hepatol; 2021 Feb; 36(2):320-328. PubMed ID: 32815163
[TBL] [Abstract][Full Text] [Related]
9. Reduced Akkermansia muciniphila and Faecalibacterium prausnitzii levels in the gut microbiota of children with allergic asthma.
Demirci M; Tokman HB; Uysal HK; Demiryas S; Karakullukcu A; Saribas S; Cokugras H; Kocazeybek BS
Allergol Immunopathol (Madr); 2019; 47(4):365-371. PubMed ID: 30765132
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of bacterial biomarkers to aid in challenging inflammatory bowel diseases diagnostics and subtype classification.
Lopez-Siles M; Aldeguer X; Sabat-Mir M; Serra-Pagès M; Duncan SH; Flint HJ; Garcia-Gil LJ; Martinez-Medina M
World J Gastrointest Pathophysiol; 2020 May; 11(3):64-77. PubMed ID: 32435523
[TBL] [Abstract][Full Text] [Related]
11. Microbiota of de-novo pediatric IBD: increased Faecalibacterium prausnitzii and reduced bacterial diversity in Crohn's but not in ulcerative colitis.
Hansen R; Russell RK; Reiff C; Louis P; McIntosh F; Berry SH; Mukhopadhya I; Bisset WM; Barclay AR; Bishop J; Flynn DM; McGrogan P; Loganathan S; Mahdi G; Flint HJ; El-Omar EM; Hold GL
Am J Gastroenterol; 2012 Dec; 107(12):1913-22. PubMed ID: 23044767
[TBL] [Abstract][Full Text] [Related]
12. Dietary Factors and Modulation of Bacteria Strains of
Verhoog S; Taneri PE; Roa Díaz ZM; Marques-Vidal P; Troup JP; Bally L; Franco OH; Glisic M; Muka T
Nutrients; 2019 Jul; 11(7):. PubMed ID: 31336737
[No Abstract] [Full Text] [Related]
13. Alterations in the relative abundance of
Björkqvist O; Repsilber D; Seifert M; Brislawn C; Jansson J; Engstrand L; Rangel I; Halfvarson J
Scand J Gastroenterol; 2019 May; 54(5):577-585. PubMed ID: 31104514
[No Abstract] [Full Text] [Related]
14. Expression of CCR6 and CXCR6 by Gut-Derived CD4
Godefroy E; Alameddine J; Montassier E; Mathé J; Desfrançois-Noël J; Marec N; Bossard C; Jarry A; Bridonneau C; Le Roy A; Sarrabayrouse G; Kerdreux E; Bourreille A; Sokol H; Jotereau F; Altare F
Gastroenterology; 2018 Oct; 155(4):1205-1217. PubMed ID: 29981781
[TBL] [Abstract][Full Text] [Related]
15. Increased proportions of Bifidobacterium and the Lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel disease.
Wang W; Chen L; Zhou R; Wang X; Song L; Huang S; Wang G; Xia B
J Clin Microbiol; 2014 Feb; 52(2):398-406. PubMed ID: 24478468
[TBL] [Abstract][Full Text] [Related]
16. Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics.
Lopez-Siles M; Duncan SH; Garcia-Gil LJ; Martinez-Medina M
ISME J; 2017 Apr; 11(4):841-852. PubMed ID: 28045459
[TBL] [Abstract][Full Text] [Related]
17. Differential modulation by Akkermansia muciniphila and Faecalibacterium prausnitzii of host peripheral lipid metabolism and histone acetylation in mouse gut organoids.
Lukovac S; Belzer C; Pellis L; Keijser BJ; de Vos WM; Montijn RC; Roeselers G
mBio; 2014 Aug; 5(4):. PubMed ID: 25118238
[TBL] [Abstract][Full Text] [Related]
18. Low counts of Faecalibacterium prausnitzii in colitis microbiota.
Sokol H; Seksik P; Furet JP; Firmesse O; Nion-Larmurier I; Beaugerie L; Cosnes J; Corthier G; Marteau P; Doré J
Inflamm Bowel Dis; 2009 Aug; 15(8):1183-9. PubMed ID: 19235886
[TBL] [Abstract][Full Text] [Related]
19. Exploring the genetic diversity of the 16S rRNA gene of
Lo Presti A; Del Chierico F; Altomare A; Zorzi F; Cella E; Putignani L; Guarino MPL; Monteleone G; Cicala M; Angeletti S; Ciccozzi M
Future Microbiol; 2019 Nov; 14():1497-1509. PubMed ID: 31850811
[No Abstract] [Full Text] [Related]
20. Alterations of mucosal microbiota in the colon of patients with inflammatory bowel disease revealed by real time polymerase chain reaction amplification of 16S ribosomal ribonucleic acid.
Kabeerdoss J; Jayakanthan P; Pugazhendhi S; Ramakrishna BS
Indian J Med Res; 2015 Jul; 142(1):23-32. PubMed ID: 26261163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]